Associations between per- and polyfluoroalkyl substances and adolescent non-alcoholic fatty liver disease.
作者信息
Zhao Longgang, Zhang Xinyuan, Ducatman Alan, Zhang Xuehong
机构信息
Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Department of Occupational and Environmental Health Sciences, West Virginia University School of Public Health, Morgantown, WV, USA.
出版信息
J Hepatol. 2023 Nov;79(5):e208-e210. doi: 10.1016/j.jhep.2023.07.008. Epub 2023 Jul 23.
Abstract
摘要
相似文献
1
Associations between per- and polyfluoroalkyl substances and adolescent non-alcoholic fatty liver disease.
J Hepatol. 2023 Nov;79(5):e208-e210. doi: 10.1016/j.jhep.2023.07.008. Epub 2023 Jul 23.
2
Per- and Polyfluoroalkyl Substances and Obesity, Type 2 Diabetes and Non-alcoholic Fatty Liver Disease: A Review of Epidemiologic Findings.
Toxicol Environ Chem. 2020;102(1-4):1-36. doi: 10.1080/02772248.2020.1763997. Epub 2020 May 22.
3
Per- and polyfluoroalkyl substances exposures are associated with non-alcoholic fatty liver disease, particularly fibrosis.
Environ Pollut. 2025 May 1;372:126085. doi: 10.1016/j.envpol.2025.126085. Epub 2025 Mar 18.
4
Association of per- and polyfluoroalkyl substance exposure with fatty liver disease risk in US adults.
JHEP Rep. 2023 Feb 3;5(5):100694. doi: 10.1016/j.jhepr.2023.100694. eCollection 2023 May.
5
Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
J Expo Sci Environ Epidemiol. 2023 Sep;33(5):748-756. doi: 10.1038/s41370-023-00529-x. Epub 2023 Mar 24.
6
Per- and polyfluoroalkyl substances activate UPR pathway, induce steatosis and fibrosis in liver cells.
Environ Toxicol. 2023 Jan;38(1):225-242. doi: 10.1002/tox.23680. Epub 2022 Oct 17.
7
Association of per- and polyfluoroalkyl substances with hepatic steatosis and metabolic dysfunction-associated fatty liver disease among patients with acute coronary syndrome.
Ecotoxicol Environ Saf. 2023 Oct 1;264:115473. doi: 10.1016/j.ecoenv.2023.115473. Epub 2023 Sep 16.
8
Associations of per- and polyfluoroalkyl substances and nonalcoholic fatty liver disease in the United States adult population, 2003-2018.
Environ Epidemiol. 2024 Jan 10;8(1):e284. doi: 10.1097/EE9.0000000000000284. eCollection 2024 Feb.
9
Effects of mixed exposure to PFAS on adolescent non-alcoholic fatty liver disease: Integrating evidence from human cohorts, toxicogenomics, and animal models to uncover mechanisms and potential target sites.
J Hazard Mater. 2025 Mar 5;485:136854. doi: 10.1016/j.jhazmat.2024.136854. Epub 2024 Dec 12.
10
Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.
Gut. 2019 Sep;68(9):1667-1675. doi: 10.1136/gutjnl-2018-317666. Epub 2018 Nov 24.
本文引用的文献
1
Association of per- and polyfluoroalkyl substance exposure with fatty liver disease risk in US adults.
JHEP Rep. 2023 Feb 3;5(5):100694. doi: 10.1016/j.jhepr.2023.100694. eCollection 2023 May.
2
The exposome and liver disease - how environmental factors affect liver health.
J Hepatol. 2023 Aug;79(2):492-505. doi: 10.1016/j.jhep.2023.02.034. Epub 2023 Mar 6.
3
Association of Prenatal Exposure to Endocrine-Disrupting Chemicals With Liver Injury in Children.
JAMA Netw Open. 2022 Jul 1;5(7):e2220176. doi: 10.1001/jamanetworkopen.2022.20176.
4
Exposure to per- and Polyfluoroalkyl Substances and Markers of Liver Injury: A Systematic Review and Meta-Analysis.
Environ Health Perspect. 2022 Apr;130(4):46001. doi: 10.1289/EHP10092. Epub 2022 Apr 27.
5
Nonalcoholic Fatty Liver Disease in Children with Obesity: Narrative Review and Research Gaps.
Horm Res Paediatr. 2022;95(2):167-176. doi: 10.1159/000518595. Epub 2021 Jul 21.
6
Prenatal Exposure to Perfluoroalkyl Substances Associated With Increased Susceptibility to Liver Injury in Children.
Hepatology. 2020 Nov;72(5):1758-1770. doi: 10.1002/hep.31483. Epub 2020 Oct 19.
7
Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach.
Environ Int. 2020 Jan;134:105220. doi: 10.1016/j.envint.2019.105220. Epub 2019 Nov 16.
8
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.
Clin Gastroenterol Hepatol. 2019 Jan;17(1):156-163.e2. doi: 10.1016/j.cgh.2018.04.043. Epub 2018 Apr 26.
9
Prevalence of fatty liver in children and adolescents.
Pediatrics. 2006 Oct;118(4):1388-93. doi: 10.1542/peds.2006-1212.
Zotero 插件